Tranquirit

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tranquirit

What is Tranquirit?

Tranquirit is a medication containing diazepam, a substance belonging to the benzodiazepine class. It is primarily used for its effects on the central nervous system to help manage symptoms related to anxiety and certain neurological conditions.

Therapeutic Purpose

This medication is characterized by its ability to enhance the activity of specific neurotransmitters in the brain that promote a calming effect. It is typically utilized for the following indications:

  • Anxiety Disorders: The management of severe or disabling anxiety symptoms that interfere with daily functioning.
  • Insomnia: Short-term relief of sleep disturbances when anxiety is a contributing factor.
  • Muscle Spasms: The reduction of muscle tension and spasms associated with various physical conditions.
  • Seizure Management: Use as an adjunctive treatment for certain types of convulsive disorders.
  • Alcohol Withdrawal: Management of acute symptoms associated with the cessation of alcohol consumption, such as agitation or tremors.

How it Functions

Tranquirit works by modulating the GABAA receptors in the brain. By increasing the efficiency of gamma-aminobutyric acid (GABA), a natural inhibitory chemical, the medication helps to reduce excessive neuronal activity. This results in the sedative, muscle-relaxant, and anticonvulsant properties associated with the drug.

Duration of Action

As a long-acting benzodiazepine, the active component is absorbed and processed by the body in a way that provides sustained effects. It is broken down by the liver into several active metabolites, which contribute to the overall duration of its therapeutic impact. Because it remains in the system for an extended period, it is generally intended for short-term use to prevent accumulation or physiological adaptation.

Regulatory References

  1. MedlinePlus: Diazepam

What side effects are possible with Tranquirit?

Possible Side Effects and Safety Information

Tranquirit (Diazepam) has a well-defined safety profile documented in regulatory sources, including those from the FDA and EMA. The occurrence of side effects is officially classified by frequency.

Documented Adverse Reactions

Frequency Classification Examples of Documented Reactions
Very Common Drowsiness, Fatigue
Common Ataxia (impaired coordination), Dizziness, Confusion, Slurred speech, Tremor
Not Known Paradoxical reactions (e.g., aggression, agitation), Respiratory depression, Drug dependence, Jaundice

These effects are often dose-dependent and more likely to occur at the start of treatment.

Serious Safety Considerations

The most significant risks documented in official labeling include Respiratory Depression (dangerously slow or shallow breathing) and the potential for developing Drug Dependence and severe Withdrawal Symptoms upon abrupt cessation, particularly following long-term exposure. In rare instances, Paradoxical Reactions, such as increased aggression or hallucinations, may occur.

Population-Specific Constraints

Official documents mandate specific caution for certain groups:

  • Older Adults: Increased sensitivity leads to a higher risk of sedation, confusion, and subsequent falls.
  • Hepatic Impairment: The drug is contraindicated in patients with severe hepatic insufficiency.
  • Pregnancy and Lactation: Use is generally advised against due to potential risks to the fetus or infant.

Regulatory Restrictions

Tranquirit is officially contraindicated in conditions such as Myasthenia Gravis, Severe Respiratory Insufficiency, Sleep Apnea Syndrome, and Acute Narrow-Angle Glaucoma.

Overdose and Emergency Response

The official regulatory profile for Tranquirit overdose describes a spectrum of central nervous system (CNS) depression. Initial documented manifestations include drowsiness, lethargy, confusion, ataxia (loss of coordination), and slurred speech. Life-threatening outcomes are listed in official labeling, primarily involving the cardiopulmonary system: respiratory depression (slowed or stopped breathing), profound sedation progressing to coma, and cardiovascular collapse.

The most severe consequences are strongly associated with concomitant use of other CNS depressants, such as opioids or alcohol, a factor explicitly warned about in regulatory prescribing information. Furthermore, elderly patients and individuals with impaired hepatic or renal function are noted to have a documented risk of drug accumulation and heightened toxicity following an overdose.

Regulators mandate that individuals seek immediate medical attention or call emergency services (e.g., 911) right away for any suspected overdose or for the presence of symptoms such as breathing difficulty or profound sedation. Management procedures detailed in official documents focus on symptomatic and supportive treatment, continuous monitoring of vital signs, and maintaining an adequate airway. Flumazenil is a benzodiazepine antagonist that may be used in management, but its administration is subject to specific regulatory warnings.

Therapeutic Uses of Tranquirit

What Tranquirit Treats: Main Uses and Benefits

Tranquirit is generally used to provide supportive relief in situations involving certain distressing symptoms linked to heightened physiological activity. Official medical information indicates the active ingredient is generally used to help with symptoms related to certain seizure disorders and to relieve panic attacks. It is relevant in areas where supportive symptom management is appropriate, particularly for symptoms that interfere with daily functioning.

Symptomatic Domains and Patient Benefits

Tranquirit is applied across domains where additional symptomatic support is needed. It helps address symptom clusters that may become intense, such as the overwhelming worry and fear of acute anxiety, the physical symptoms of involuntary muscle spasms or tension, and the agitation associated with acute episodes like alcohol withdrawal. It is generally relevant for conditions characterized by periods of heightened symptoms.

“Tranquirit may assist with easing symptoms that create noticeable functional strain, supporting the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Acute Tension Tranquirit supports general well-being during symptomatic phases by helping to calm the body's acute physical responses, assists with maintaining functional stability when tension or spasms are pronounced.

Regulatory References

  1. NIH MedlinePlus overview of Clonazepam

Eligibility and Restrictions for Use

Who Can and Cannot Use Tranquirit?

The population-eligibility rules for Tranquirit (Diazepam) are strictly defined by regulatory authorities and based on absolute prohibitions, age limitations, and specific pre-existing conditions.

Contraindicated Populations

Use of this medicine is absolutely contraindicated and prohibited for patients with certain severe conditions, including severe hepatic insufficiency (severe liver disease), severe respiratory insufficiency, myasthenia gravis, and sleep apnoea syndrome. It must also not be used by individuals with a known hypersensitivity to the active ingredient or any excipient.

Age and Physiological Restrictions

Tranquirit is not recommended for or contraindicated in infants under six months of age. For older adults and the very ill, use requires extreme caution and the dose should not exceed half the adult recommendation. The drug is generally not recommended during pregnancy (former FDA Category D) and is excreted into human milk, requiring monitoring or discontinuation during lactation.

Conditional Use Requirements

Official labeling mandates restricted use for several populations. A lower dose is recommended for patients with chronic respiratory insufficiency and for those with mild or moderate hepatic disease. Use requires extreme caution in patients with a history of alcohol or drug abuse due to the enhanced risk of dependence.

What should I know about interactions with other medicines?

The official interaction profile for Tranquirit (Diazepam) is defined by its susceptibility to pharmacokinetic changes related to metabolic clearance and risks associated with pharmacodynamic augmentation of Central Nervous System (CNS) depression.

Contraindications and Restrictions

Co-administration with Opioids is highly restricted due to the documented risk of profound sedation, respiratory depression, coma, and death. Simultaneous ingestion of Alcohol must be avoided due to enhanced CNS depressant effects, and the regulatory label also prohibits co-use with Sodium Oxybate.

Metabolic and Exposure Effects

Diazepam is primarily metabolized by the hepatic enzymes CYP2C19 and CYP3A4. Inhibitors of these enzymes (e.g., Cimetidine, Fluconazole) decrease the drug’s elimination rate, officially resulting in increased plasma concentration. Conversely, inducers (e.g., Phenytoin, Rifampin) increase the elimination rate, potentially leading to reduced plasma concentration. The compound Valproate also increases the drug’s free fraction by displacing it from plasma protein binding sites.

Food, Substance, and Timing Constraints

Certain food products have documented effects; Grapefruit Juice may increase plasma levels, and a moderate fat meal may delay and decrease oral tablet absorption. The specific buccal film formulation has a mandatory constraint that it must not be taken at the same time as drinking liquids. Additionally, Tranquirit is contraindicated in patients with severe hepatic insufficiency, a condition that significantly impedes the drug’s metabolic clearance.

Mechanism of Action

GABA A Receptor Modulation and Neuronal Hyperpolarization

Tranquirit (Diazepam) operates by acting as a Positive Allosteric Modulator (PAM) at the Benzodiazepine binding site of the GABA A receptor complex, a fundamental inhibitory target. This mechanism amplifies the effect of the endogenous neurotransmitter GABA, causing the receptor's integral Chloride ion ( Cl^-) channel to open more frequently. The resulting rapid influx of negative Cl^- charge causes neuronal hyperpolarization, making the nerve cell less excitable and less likely to propagate an electrical signal.


Generalized CNS Depression and Pathway Dampening

The hyperpolarization cascade produces a generalized depression of electrical activity across multiple key Central Nervous System (CNS) regions due to the drug's non-selective binding to several GABA A R subtypes. This mechanism dampens hyperactivity in the limbic system and suppresses signaling within the spinal cord's polysynaptic reflex pathways, which reduces muscle tone. This widespread inhibition across diverse functional circuits influences the neuronal activity within the pathways governing motor control, arousal, and emotional regulation.


Mechanistic Constraints and Tolerance

The sustained presence of Diazepam can initiate adaptive biological changes in the GABA A R, leading to phenomena like receptor uncoupling and potentially downregulation. These structural changes cause the mechanism to become progressively less effective over time—a process known as tolerance—which results in a diminished potentiation effect upon prolonged use.

Dosage and Administration Information

How to use Tranquirit — Administration Guidelines

Tranquirit is administered via the oral route (as drops or tablets) and rectal route (as gel or solution). The following details outline the documented methods for use.

Administration Procedure

  • Route and Preparation: The oral drops must be diluted in water or another beverage before administration. To ensure the correct dosage, the bottle should be held vertically with the opening facing down when dispensing.
  • Timing: For the treatment of insomnia, the drug must be taken immediately at bedtime.

Dosing and Duration

Age Group / Condition Dosing Schedule Maximum Duration
Adults (Oral Drops) 15–25 drops (3–5 mg) repeated 2–3 times per day Anxiety/Tension: 8–12 weeks, including withdrawal
Children (4–14 years) 20–60 drops (4–12 mg) per day (Only for absolute necessity) Not explicitly stated; use for shortest time possible
Elderly / Debilitated Patients 10 drops (2 mg) repeated 2–3 times per day Same as adults, but initial dose reduction is mandatory
  • Dose Principle: Treatment must always begin with the lowest recommended dose. The dosage must be adapted case-by-case, and the maximum dose should not be exceeded.
  • Treatment Limit: The treatment duration, which includes a required gradual withdrawal phase, should not exceed four weeks for insomnia or eight to twelve weeks for anxiety. Any extension beyond these limits mandates a re-evaluation of the patient's condition by a medical professional.

Recent Clinical Evidence

The evidence landscape for the active ingredient in Tranquirit, Diazepam, includes findings from various types of studies, including controlled trials and long-term observational monitoring. The evidence base includes descriptions of what was measured and observed in specific patient groups.


Evidence for Short-Term Relief of Severe Anxiety Symptoms

Research has explored the medication for severe anxiety using short-term, randomized controlled trials (RCTs), often compared against a placebo. These studies monitored outcomes related to functional imbalance, such as changes measured on established anxiety rating scales. Findings describe patterns observed where the measured anxiety scores changed during the short study period, which is typically a few weeks long. Follow-up durations were limited in most efficacy trials, meaning that long-term effects are not fully established.


Evidence for Acute Repetitive Seizures (Seizure Clusters)

The use in acute repetitive seizures has been evaluated in controlled research settings, including placebo-controlled trials and specialized research on formulations developed for rapid delivery. These studies monitored outcomes related to the time elapsed until the seizure cessation. Research highlights measured changes related to the cessation of the acute seizure episode. However, the results apply only to the specific context of intermittent, rescue intervention. Limited information is available from controlled trials for very young children.


Evidence for Muscle Spasm and Acute Alcohol Withdrawal

The evidence base for adjunctive therapy includes trials and systematic reviews exploring skeletal muscle spasm (examining outcomes related to physical discomfort) and acute alcohol withdrawal syndrome (focused on monitoring physiological strain). Findings describe patterns observed where the drug was associated with changes in acute withdrawal symptoms. Evidence quality varies across studies, and the findings primarily reflect observations made in a supervised, acute care setting.


Evidence in Special Populations and Research Gaps

Pediatric patients (children) were evaluated in specific acute care trials for seizure clusters, although data for the youngest infants remains insufficient. The drug was observed in studies of older adults, where age-related considerations were noted. Comparative evidence is lacking in some areas, and there is limited information on durability of response for chronic conditions.

Key Studies & References WHO Model List of Essential Medicines (Relevant Benzodiazepine Chapter)

Frequently Asked Questions (FAQ)

Common questions about Tranquirit (FAQ)


Q: How quickly does the effect of Tranquirit usually begin after taking it?

According to the official clinical pharmacology information, the initial phase of the drug's distribution begins quickly after oral administration. This initial distribution has a half-life of about one hour, which is the general timeframe when initial effects may be observed. Individual experience may vary based on the specific formulation and personal metabolism.


Q: Is there a generic version of Tranquirit available on the market?

Yes, the active ingredient in Tranquirit is Diazepam, which is widely available as a generic medicine. Many manufacturers produce and supply this generic version in addition to the original brand-name products.


Q: Does Tranquirit affect the ability to drive or operate machinery?

Official warnings state that this medication may impair key functions such as coordination, reaction time, or judgment. For this reason, regulatory documents caution against driving or operating machinery until the full effect of the medicine is known.


Q: What happens if a user accidentally takes more Tranquirit than intended?

Taking more than the prescribed amount is considered a medical emergency. Signs of an accidental overdose can include confusion, slurred speech, excessive drowsiness, shallow breathing, or loss of consciousness. If this occurs, prompt medical intervention is necessary.


Q: How long does Tranquirit stay in the body after the last dose?

Tranquirit is known for its long duration in the body. The main drug has a terminal elimination half-life of up to 48 hours, but its active breakdown product, known as an active metabolite, can remain for up to 100 hours. This long half-life contributes to the drug's overall effects.


Q: Does Tranquirit cause weight gain or weight loss?

While not listed as a common direct effect on weight, regulatory adverse event data has mentioned changes in appetite. These changes can include both an increase or a decrease in appetite, which might indirectly influence a person’s weight over time.


Q: What are the common reasons people stop taking Tranquirit, according to studies?

According to the official product label, major safety concerns relate to the risk of developing physical dependence and severe withdrawal symptoms if the medication is stopped suddenly. These serious warnings often lead to a controlled, gradual dose tapering or discontinuation under medical supervision.


Q: Does Tranquirit require any special monitoring or blood tests during use?

Regulatory safety information indicates that patients with impaired liver function require specific caution and monitoring. In clinical practice, blood tests may be used in certain situations to monitor the drug’s concentration or liver health.


Q: What if a person forgets to take a dose of Tranquirit?

Official guidance for a missed dose involves taking it as soon as it is remembered, unless it is closer to the time of the next dose. If so, the missed dose is skipped. Regulatory instructions emphasize that a double dose should not be taken to compensate for a missed one.


Q: Does Tranquirit affect blood pressure or heart rate?

The official label lists hypotension, which is low blood pressure, as a documented adverse cardiovascular effect. Changes in heart rate may occur secondary to this drop in blood pressure.


Q: What type of specialist typically prescribes Tranquirit?

As a prescription-only medicine, Tranquirit is commonly prescribed by various healthcare professionals. This often includes General Practitioners, as well as specialists like Neurologists (for conditions like muscle spasms) and Psychiatrists (for conditions like anxiety).


Q: Is Tranquirit known to cause any skin reactions or rashes?

Yes, regulatory documents note that signs of a serious adverse effect, such as an allergic reaction, can include hives or a skin rash. The onset of these serious symptoms is described as a condition requiring immediate medical intervention.


Q: Does Tranquirit interact with common over-the-counter pain relievers?

Regulatory guidance generally suggests that there is no known significant interaction when Tranquirit is taken with common non-prescription pain relievers such as ibuprofen or acetaminophen. These medications are not known to interact significantly.


Q: Can people with liver or kidney problems use Tranquirit?

The official product information states that severe liver insufficiency is an absolute contraindication (prohibition). For patients with kidney impairment (renal issues), regulatory warnings advise extreme caution and often require a dose reduction due to the risk of the medicine’s breakdown products accumulating in the body.


Q: Does Tranquirit affect sleep patterns, such as causing insomnia or excessive sleepiness?

While the medicine is known for its sedative effects, regulatory documents note that it can rarely cause paradoxical reactions. These unusual reactions can include symptoms opposite to the expected effect, such as insomnia (difficulty sleeping), agitation, or hyperactive behavior.


Q: Can I take vitamins or herbal supplements while using Tranquirit?

Certain herbal products, such as St. John’s Wort or Kava, may have documented effects on the medicine's metabolism or its effects on the central nervous system. Official guidance stresses that consultation with a healthcare provider is required before combining any supplements with this medicine.


Q: Can Tranquirit be used by people with a history of seizures?

Tranquirit is approved for use in the short-term treatment of acute seizure episodes. However, in people with a general history of seizures or epilepsy, regulatory warnings advise that abrupt withdrawal of the medicine can potentially worsen seizure activity or induce convulsions.


Q: Is there a documented risk of allergic reaction to Tranquirit?

Yes, the medicine is absolutely contraindicated (prohibited) in patients with a known hypersensitivity to the active ingredient, Diazepam, or any other components in the product. Hypersensitivity is the regulatory term for a severe allergic reaction.

How should Tranquirit be stored and disposed of?

How to Store and Dispose of Tranquirit?

Tranquirit (Diazepam) must be stored and disposed of following strict regulatory requirements, particularly as a Controlled Substance (Schedule IV) to ensure stability and prevent accidental harm or misuse.


Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature (20 C to 25 C)
Protection Keep from freezing and protect from light.
Container Store in a tightly closed, light-resistant container.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Official regulatory guidance mandates that unused or expired Tranquirit be disposed of securely. The preferred method is using authorized drug take-back programs. If a take-back option is unavailable, the product should be mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed container before discarding in household trash, following FDA recommendations for controlled substances.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tranquirit found in:

A-Z Index: